1.
Dalton Trans
; 51(34): 12791-12795, 2022 Aug 30.
Article
in English
| MEDLINE
| ID: mdl-35920379
ABSTRACT
Rhenium-based metallodrugs have recently been highlighted as promising candidates for new antibiotics to combat multi-drug resistant (MDR) pathogens. A new class of rhenium(V) dioxo complexes were prepared from readily accessible diphosphine ligands, and have been shown to possess potent activity against Staphylococcus aureus (S. aureus) and Candida albicans (C. albicans) alongside low human cell toxicity.